Cargando…
Low levels of circulating anti-ageing hormone Klotho predict the onset and progression of diabetic retinopathy
BACKGROUND: Klotho is a circulating anti-ageing hormone that predicts progression of cardiovascular and renal disease. The role of Klotho in diabetic retinopathy is unknown. METHODS: We performed a single-centre observational study of 81 people (males 62%) with type 2 diabetes followed for a median...
Autores principales: | Corcillo, Antonella, Fountoulakis, Nikolaos, Sohal, Angela, Farrow, Frederick, Ayis, Salma, Karalliedde, Janaka |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7919202/ https://www.ncbi.nlm.nih.gov/pubmed/33225726 http://dx.doi.org/10.1177/1479164120970901 |
Ejemplares similares
-
Does Dapagliflozin influence arterial stiffness and levels of circulating anti-aging hormone soluble Klotho in people with type 2 diabetes and kidney disease? Results of a randomized parallel group clinical trial
por: Karalliedde, Janaka, et al.
Publicado: (2022) -
Perturbations of the anti-ageing hormone Klotho in patients with type 1 diabetes and microalbuminuria
por: Maltese, Giuseppe, et al.
Publicado: (2017) -
Diabetic retinopathy is independently associated with increased risk of intubation: A single centre cohort study of patients with diabetes hospitalised with COVID-19
por: Corcillo, Antonella, et al.
Publicado: (2021) -
Painless foot drop: an unusual acute presentation of new onset type 1 diabetes mellitus
por: Corcillo, Antonella, et al.
Publicado: (2021) -
Effect of calcitriol treatment on arterial stiffness in people with type 2 diabetes and stage 3 chronic kidney disease
por: Karalliedde, Janaka, et al.
Publicado: (2022)